Age-Dependent Cancer Risk Is Not Different in between MSH2 and MLH1 Mutation Carriers.
Lynch syndrome is mostly characterized by early-onset colorectal and endometrial adenocarcinomas. Over 90% of the causal mutations occur in two mismatch repair genes, MSH2 and MLH1. The aim of this study was to evaluate the age-dependent cancer risk in MSH2 or MLH1 mutation carriers from data of DNA diagnostic laboratories. To avoid overestimation, evaluation was based on the age-dependent proportion of mutation carriers in asymptomatic first-degree relatives of identified mutation carriers. Data from 859 such eligible relatives were collected from 8 centers; 387 were found to have inherited the mutation from their relatives. Age-dependent risks were calculated either using a nonparametric approach for four discrete age groups or assuming a modified Weibull distribution for the dependence of risk on age. Cancer risk was estimated starting at 28 (25-32 0.68 confidence interval) and to reach near 0.70 at 70 years. The risks were very similar for MSH2 and MLH1 mutation carriers. Although not statistically significant, the risk in males appeared to precede that for females by ten years. This difference needs to be investigated on a larger dataset. If confirmed, this would indicate that the onset of the colonoscopic surveillance may be different in male and female mutation carriers.
Olschwang
Sylviane
S
Institut National de la Santé et de la Recherche Médicale (INSERM), Unité 891, Centre de Recherches en Cancérologie de Marseille, 13009 Marseille, France.
Yu
Kai
K
Lasset
Christine
C
Baert-Desurmont
Stéphanie
S
Buisine
Marie-Pierre
MP
Wang
Qing
Q
Hutter
Pierre
P
Rouleau
Etienne
E
Caron
Olivier
O
Bourdon
Violaine
V
Thomas
Gilles
G
Cancer. 1993 Feb 1;71(3):677-85
8431847
Cancer Res. 2000 Jun 1;60(11):2760-3
10850409
J Natl Cancer Inst. 2006 Dec 6;98(23):1675-7
17148764
Gastroenterology. 1996 Apr;110(4):1020-7
8612988
J Med Genet. 2007 Jun;44(6):353-62
17327285
JAMA. 2006 Sep 27;296(12):1507-17
17003399
J Med Genet. 2003 Mar;40(3):208-13
12624141
J Clin Oncol. 2000 Jun;18(11):2193-200
10829038
J Med Genet. 2000 Sep;37(9):641-5
10978352
Hum Mol Genet. 1997 Jan;6(1):105-10
9002677
Int J Cancer. 1999 Apr 12;81(2):214-8
10188721
Clin Genet. 2008 Sep;74(3):233-42
18554281
J Med Genet. 2005 Jun;42(6):491-6
15937084
Hum Hered. 2008;66(4):238-51
18612208
Stat Med. 2007 Apr 15;26(8):1775-87
17243094
Gastroenterology. 1999 Jun;116(6):1453-6
10348829